Screening Filters
Price ≥ $3
- Purpose: Exclude very low‑priced “penny stocks.”
- Rationale: Penny stocks (typically under $3) are often illiquid, highly volatile, and more prone to manipulation. For a short‑term biotech idea list that’s actually tradable for most investors, focusing on stocks above $3 improves liquidity and execution quality, and reduces extreme risk.
RSI Category: Moderate
- Purpose: Avoid stocks that are extremely overbought or oversold.
- Rationale:
- Overbought stocks (very high RSI) may have already made their move and be at higher risk of a near‑term pullback.
- Oversold stocks (very low RSI) can be in sharp downtrends, where “cheap” can get cheaper.
Choosing a moderate RSI range keeps the focus on names that are not at extreme momentum extremes, which is more consistent with short‑term entries that don’t rely on perfectly timing reversals or chasing blow‑off moves.
PriceAboveMA20 (Price above 20‑day moving average)
- Purpose: Ensure the stock is in a positive short‑term trend.
- Rationale: A 20‑day moving average is roughly one trading month and is a common short‑term trend gauge. Requiring price to be above the 20‑day MA:
- Filters for names with upward or at least stable short‑term momentum.
- Matches the “right now” and “short term” focus by favoring stocks already acting constructively, instead of ones still in clear downtrends.
1‑Week Price Change %: Between −100% and +100%
- Purpose: Set broad, realistic bounds on weekly price movement (effectively neutral here).
- Rationale: This range is so wide it doesn’t meaningfully restrict the universe; it mainly ensures we don’t include clearly erroneous data (e.g., mispriced securities). In practice, this is a “no additional filter” on the past week’s move, letting the predictive indicators (below) drive the short‑term selection instead of simply chasing last week’s winners or losers.
Industry: Biotechnology & Medical Research
- Purpose: Restrict the universe strictly to biotech‑related companies.
- Rationale: This directly matches your request for “best biotech stocks”. It excludes pharma conglomerates, general healthcare, and other sectors, and focuses on pure or primary biotech / medical research businesses.
Exchange: XNYS, XNAS, XASE (NYSE, Nasdaq, NYSE American)
- Purpose: Focus on major, regulated U.S. exchanges.
- Rationale:
- These exchanges typically offer better liquidity, tighter spreads, and more robust disclosure standards.
- Most investors using U.S. brokers can easily trade these stocks.
This supports your goal of “stocks to buy” by ensuring the results are practical to trade and backed by reliable market data.
One‑Week Rise Probability ≥ 60%
- Purpose: Emphasize stocks with a higher modeled probability of rising over the next week.
- Rationale: This is a short‑term quantitative indicator derived from historical patterns and current conditions. By requiring at least a 60% probability of a one‑week gain, the screener:
- Directly targets your “short term” horizon (about a week).
- Prefers names where the odds of an upward move, based on our model, are meaningfully better than a coin flip.
One‑Week Predicted Return ≥ 3%
- Purpose: Focus on stocks with attractive expected upside over the coming week.
- Rationale: A minimum expected gain of 3% in one week is a strong short‑term target. Combined with the rise probability filter, this ensures we’re not just looking for any positive move, but for biotech names with:
- Statistically higher odds of going up, and
- A meaningful forecasted magnitude of that move.
Sorting (not a filter but important):
- Sort 1: One‑week predicted return, descending – ranks the list so the highest expected short‑term upside appears first, aligning with “best … to buy right now.”
- Sort 2: 1‑week price change %, descending – as a tie‑breaker, gives some preference to names that have already been acting relatively strong recently, within that biotech universe.
Why Results Match Your Request
- Biotech focus: The industry filter ensures all candidates are in Biotechnology & Medical Research, precisely matching “best biotech stocks.”
- Short‑term orientation:
- PriceAboveMA20 and moderate RSI capture favorable near‑term technical setups.
- The one‑week rise probability and one‑week predicted return directly encode a short‑term (about 1 week) time frame into the screen.
- Tradability & risk control:
- The price ≥ $3 and major exchange filters aim for more liquid, better‑regulated names, reducing some of the most extreme risks typical in micro‑cap biotech.
We don’t rely on any indicators you didn’t ask for; instead, we use common technical and predictive factors that map well onto your broad request (“best,” “right now,” and “short term”) while staying realistic and focused on probability rather than certainty.
This list is generated based on data from one or more third party data providers. It is provided for informational purposes only by Intellectia.AI, and is not investment advice or a recommendation. Intellectia does not make any warranty or guarantee relating to the accuracy, timeliness or completeness of any third-party information, and the provision of this information does not constitute a recommendation.